Schwendeman
Anna Schwendeman, Superior Township, MI US
Patent application number | Description | Published |
---|---|---|
20160074473 | EFFECT OF PHOSPHOLIPID COMPOSITION OF RECONSTITUTED HDL ON ITS CHOLESTEROL EFFLUX AND ANTI-INFLAMMATORY PROPERTIES - The present invention relates to peptide-phospholipid formulations, methods of generating these formulations and methods of administering these formulations for treatment. The present disclosure also provides methods for increasing cholesterol efflux, inducing anti-atherosclerotic activity, increasing pre-β HDL, inducing anti-inflammatory activity, inhibiting cytokine release (including cytokines TNF-α, IL-1β, and/or IL-6 or a combination thereof) and increasing cholesterol mobilization and/or esterification by administering the peptide-phospholipid formulations disclosed. | 03-17-2016 |
Anna Shenderova Schwendeman, Superior Township, MI US
Patent application number | Description | Published |
---|---|---|
20100267631 | APOLIPOPROTEIN A-I MIMICS - Provided are peptides, compositions thereof, and methods for treating or preventing dyslipidemia, a cardiovascular disease, endothelial dysfunction, a macrovascular disorder, or a microvascular disorder. | 10-21-2010 |
20130231459 | APOLIPOPROTEIN A-I MIMICS - Provided are peptides, compositions thereof, and methods for treating or preventing dyslipidemia, a cardiovascular disease, endothelial dysfunction, a macrovascular disorder, or a microvascular disorder. | 09-05-2013 |
20150141330 | APOLIPOPROTEIN A-I MIMICS - Provided are peptides, compositions thereof, and methods for treating or preventing dyslipidemia, a cardiovascular disease, endothelial dysfunction, a macrovascular disorder, or a microvascular disorder. | 05-21-2015 |
Nicholas Michael Schwendeman, Hastings, MN US
Patent application number | Description | Published |
---|---|---|
20140006071 | Consolidated Partnership Valuation Platform | 01-02-2014 |
Steven P. Schwendeman, Superior Township, MI US
Patent application number | Description | Published |
---|---|---|
20120288537 | ACTIVE SELF-HEALING BIOMATERIAL SYSTEM - Methods and compositions are provided that load and encapsulate an agent, such as a protein, in a porous self-healing polymer. A delivery system includes a porous self-healing polymer, an ionic affinity trap within the pores of the self-healing polymer, and an agent associated with the ionic affinity trap. Methods of encapsulating an agent in a polymer include providing a porous self-healing polymer comprising an ionic affinity trap within the pores. The polymer is incubated with an agent having an affinity for the ionic affinity trap. At least a portion of the pores in the polymer are then healed. Active encapsulation of macromolecules at low concentrations may be achieved due to affinity of the agent for the ionic affinity trap within the pores. | 11-15-2012 |
20150125531 | ACTIVE SELF-HEALING BIOMATERIAL SYSTEM - Methods and compositions are provided that load and encapsulate an agent, such as a protein, in a porous self-healing polymer. A delivery system includes a porous self-healing polymer, an ionic affinity trap within the pores of the self-healing polymer, and an agent associated with the ionic affinity trap. Methods of encapsulating an agent in a polymer include providing a porous self-healing polymer comprising an ionic affinity trap within the pores. The polymer is incubated with an agent having an affinity for the ionic affinity trap. At least a portion of the pores in the polymer are then healed. Active encapsulation of macromolecules at low concentrations may be achieved due to affinity of the agent for the ionic affinity trap within the pores. | 05-07-2015 |
Steven P. Schwendeman, Superior Twp., MI US
Patent application number | Description | Published |
---|---|---|
20140056949 | Controlled Release Mucoadhesive Systems - Formulations for chemoprevention of oral cancer and precancerous lesions, and for methods for preparing the formulations are described. | 02-27-2014 |